Butterfield LH - Search Results

1

Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy.

Ribas A, Glaspy JA, Lee Y, Dissette VB, Seja E, Vu HT, Tchekmedyian NS, Oseguera D, Comin-Anduix B, Wargo JA, Amarnani SN, McBride WH, Economou JS, Butterfield LH. Ribas A, et al. Among authors: butterfield lh. J Immunother. 2004 Sep-Oct;27(5):354-67. doi: 10.1097/00002371-200409000-00004. J Immunother. 2004. PMID: 15314544 Clinical Trial.

2

A comparison of gene transfer methods in human dendritic cells.

Arthur JF, Butterfield LH, Roth MD, Bui LA, Kiertscher SM, Lau R, Dubinett S, Glaspy J, McBride WH, Economou JS. Arthur JF, et al. Among authors: butterfield lh. Cancer Gene Ther. 1997 Jan-Feb;4(1):17-25. Cancer Gene Ther. 1997. PMID: 9012447

3

Cloning and analysis of MART-1/Melan-A human melanoma antigen promoter regions.

Butterfield LH, Stoll TC, Lau R, Economou JS. Butterfield LH, et al. Gene. 1997 Jun 3;191(2):129-34. doi: 10.1016/s0378-1119(96)00789-5. Gene. 1997. PMID: 9218710

4

Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells.

Ribas A, Butterfield LH, McBride WH, Jilani SM, Bui LA, Vollmer CM, Lau R, Dissette VB, Hu B, Chen AY, Glaspy JA, Economou JS. Ribas A, et al. Among authors: butterfield lh. Cancer Res. 1997 Jul 15;57(14):2865-9. Cancer Res. 1997. PMID: 9230191

5

In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2.

Bui LA, Butterfield LH, Kim JY, Ribas A, Seu P, Lau R, Glaspy JA, McBride WH, Economou JS. Bui LA, et al. Among authors: butterfield lh. Hum Gene Ther. 1997 Dec 10;8(18):2173-82. doi: 10.1089/hum.1997.8.18-2173. Hum Gene Ther. 1997. PMID: 9449371

6

Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus.

Butterfield LH, Jilani SM, Chakraborty NG, Bui LA, Ribas A, Dissette VB, Lau R, Gamradt SC, Glaspy JA, McBride WH, Mukherji B, Economou JS. Butterfield LH, et al. J Immunol. 1998 Nov 15;161(10):5607-13. J Immunol. 1998. PMID: 9820539

7

Generation of CD8+ and CD4+ T-cell response to dendritic cells genetically engineered to express the MART-1/Melan-A gene.

Pérez-Díez A, Butterfield LH, Li L, Chakraborty NG, Economou JS, Mukherji B. Pérez-Díez A, et al. Among authors: butterfield lh. Cancer Res. 1998 Dec 1;58(23):5305-9. Cancer Res. 1998. PMID: 9850054

8

Antitumor protection using murine dendritic cells pulsed with acid-eluted peptides from in vivo grown tumors of different immunogenicities.

Ribas A, Bui LA, Butterfield LH, Vollmer CM, Jilani SM, Dissette VB, Glaspy JA, McBride WH, Economou JS. Ribas A, et al. Among authors: butterfield lh. Anticancer Res. 1999 Mar-Apr;19(2A):1165-70. Anticancer Res. 1999. PMID: 10368670

9

Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma.

Vollmer CM Jr, Eilber FC, Butterfield LH, Ribas A, Dissette VB, Koh A, Montejo LD, Lee MC, Andrews KJ, McBride WH, Glaspy JA, Economou JS. Vollmer CM Jr, et al. Among authors: butterfield lh. Cancer Res. 1999 Jul 1;59(13):3064-7. Cancer Res. 1999. PMID: 10397245

10

Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein.

Butterfield LH, Koh A, Meng W, Vollmer CM, Ribas A, Dissette V, Lee E, Glaspy JA, McBride WH, Economou JS. Butterfield LH, et al. Cancer Res. 1999 Jul 1;59(13):3134-42. Cancer Res. 1999. PMID: 10397256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters